AlphaYouMS
Insider buying
Maged Shenouda bought $844K of Relmada Therapeutics, Inc. (RLMD) stock
Maged Shenouda, Chief Financial Officer of Relmada Therapeutics, Inc. (RLMD), bought 200,000 shares of RLMD stock worth $844K, per an SEC Form 4 filed Sep 11, 2026.
It was an open-market purchase.
The trade happened on Sep 9, 2026, 2 days before it was made public.
RLMD has moved +1.7% since the trade date, from $4.09 to $4.16 (Sep 21, 2026 close).
- Traded
- Sep 9, 2026
- Disclosed
- Sep 11, 2026
- Filing delay
- 2 days
- Price since
- +1.7%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RLMD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.